Abivax Announces Presentation Of Late-Breaking Abstract For Obefazimod From Abtect Phase 3 Induction Trials At 2025 UEG Meeting

RefinitivLess than 1 min read

Abivax SA ABVX:

ABIVAX ANNOUNCES PRESENTATION OF LATE-BREAKING ABSTRACT FOR OBEFAZIMOD FROM THE ABTECT PHASE 3 INDUCTION TRIALS AT 2025 UNITED EUROPEAN GASTROENTEROLOGY (UEG) MEETING

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news